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Abstract
Graph Neural Networks (GNN) have been exten-
sively used to extract meaningful representations
from graph structured data and to perform pre-
dictive tasks such as node classification and link
prediction. In recent years, there has been a lot
of work incorporating edge features along with
node features for prediction tasks. In this work,
we present a framework for creating new edge
features, via a combination of self-supervised and
unsupervised learning which we then use along
with node features for node classification tasks.
We validate our work on two biological datasets
comprising of single-cell RNA sequencing data
of in vitro SARS-CoV-2 infection and human
COVID-19 patients. We demonstrate that our
method achieves better performance over baseline
Graph Attention Network (GAT) and Graph Con-
volutional Network (GCN) models. Furthermore,
given the attention mechanism on edge and node
features, we are able to interpret the cell types
and genes that determine the course and sever-
ity of COVID-19, contributing to a growing list
of potential disease biomarkers and therapeutic
targets.
1. Introduction
Graph neural networks (GNN) have been widely used and
developed for predictive tasks such as node classification
and link prediction [35] and have been shown to learn from
any sparse and discrete relational structure in data [12].
GNNs typically use message passing, or recursive neigh-
borhood aggregation, to construct a new feature vector for
a particular node by collecting its neighbor’s feature vec-
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tors [36, 20]. However, most GNN schemes do not use
edge features in learning new representations of graphical
data. Recently, edge features have been incorporated into
GNNs to harness information describing different aspects
of the relationships between nodes [15, 13]. However, there
are very few frameworks for creating de novo edge feature
vectors in a domain agnostic manner. In this article, using
Graph Attention Networks, we propose a self-supervised
learning framework to create new edge features which can
be used to improve GNN performance in downstream node
classification tasks.
Given the devastating impact of the coronavirus disease
of 2019 (COVID-19) caused by infection of SARS-CoV-2
and the gap in our understanding of the molecular mech-
anisms of the disease, we sought to focus our efforts on
COVID-19 datasets that can generate hypotheses related to
these gaps [37, 39]. Our focus on single-cell transcriptomic
data relating to COVID-19 was motivated by recent work
showing that Graph Attention Networks are effective at pre-
dicting disease states on an individual cell-to-cell basis [29].
Single-cell RNA sequencing (scRNA-seq) is a technology
that yields large datasets comprising many thousands of
cells’ gene expression in a variety of conditions [38, 18, 31].
However, identifying factors important for determining an
individual cell’s pathophysiological trajectory or response to
viral insult remains a challenge as single-cell data is noisy,
sparse, and multi-dimensional [8, 21]. We reasoned that
our framework’s improved performance could extract useful
insights into the genes and cell types that might be impor-
tant determinants of COVID-19 severity and SARS-CoV-2
infection.
2. Related works
There is a wealth of research on Graph Neural Networks.
A significant amount of work has been focused on graph
embedding techniques, representation learning and various
predictive analyses using node features. There has been
recent interest in using edge features to improve the perfor-
mance of Graph Neural Networks [15, 9, 1]. In this work
we use an unique multi–tasking approach in creating these
edge features.
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Since our work focuses on biological applications, it be-
comes necessary to be able to interpret the results of our
network to inform further study of biology and medicine.
One of the most common and popular ways to interpret
machine learning models is via Shapley values [26] and
it’s various generalizations [27]. However Shapley values
require independence of features which is generally hard
to guarantee. There is an excellent library [22] that allows
us to interpret PyTorch models. In this work we follow
the approach of [29, 2] in using attention mechanisms for
interpretability. Thus even though set2set [34] is a pop-
ular mechanism to encode sets and has been previously
used in the graph domain [14, 3], our view is that it is hard
to interpret the hidden state of a LSTM. The transformer
model [32, 23], on the other hand, allows us to interpret the
results by looking at their attention heads.
Even though GNNs have been extensively used in biomed-
ical research to predict medications, diagnoses, and out-
comes from graphical representations of electronic health
records [10], protein-protein and drug-protein interactions
and molecular activity [28, 7, 17, 33] there is only one re-
cent work that uses GAT models to predict the disease state
of individual cells derived from clinical samples [29]. How-
ever they do not consider multiple disease states or severity
nor do they account for the confounding bias of batch ef-
fects. Here, we use the information contained within the
dataset to construct edge features and a graph-structure that
is balanced across batches, which reduces the bias of cell
source while preserving biological variation [25]. To the
best of our knowledge, this is the first attempt to apply a
GNN model to gain insight into multiple pathophysiologi-
cal states, merging time-points, severity, and disease-state
prediction into a multi-label node classification task from
single-cell data.
3. Our Model
In this subsection we describe our model which consists of
two components: (1) Set Transformer and (2) GAT layers.
3.1. Set Transformer
We use a Set Transformer as in [23]. The Set Transformer is
permutation invariant so it is an ideal architecture to encode
sets. The building block of our Set Transformer is the multi-
head attention, as in [32]. Given n query vectors Q of
dimension dq, a key-value pair matrix K ∈ Rnv×dq and a
value matrix V ∈ Rnv×dv and for simplicity, let dq = dv =
d, the multihead attention is computed by first projecting
Q,K, V onto h different dhq , d
h
q , d
h
v dimensional vectors.
For simplicity, let dhq = d
h
v =
d
h , where h is the number of
heads.
Multihead(Q,K, V ) := concat(O1, · · · , Oh)WO
Oj := softmax
(
(QWQj )(KW
K
j )
T√
d
h
)
VWVj
and WQj ,W
K
j ,W
V
j are projection operators of dimensions
Rdq×d
h
q ,Rdq×d
h
q and Rdv×dhv respectively and WO is a lin-
ear operator of dimension d× d. Now, given a set S, the Set
Transformer Block (STB) is given the following formula:
STB(S) := LayerNorm(X + rFF (X)) (1)
where X = LayerNorm(S + Multihead(S, S, S)). rFF is a
row-wise feedforward layer and LayerNorm is layer normal-
ization [4].
A Set Transformer takes as input a 3d tensor of the form
[batch, seq-length, input-dim] and outputs 3d tensor of the
form [batch, seq-length, output-dim], i.e. it outputs sets
of the same size as the input sets. If, for a batch bi, the
set transformer outputs a set of the form {wi1, ....wij}, we
modify the output of the transformer to a fixed length vector
wi :=
∑
j
λjwij (2)
where λj are learnable weights. This step is necessary for
us because our downstream tasks require vectors of fixed
length.
3.2. Graph Attention Network
We also use the popular Graph Attention Network
(GAT) [33]. The input to a GAT layer are the node fea-
tures and it outputs a new set of node features (of possibly
different dimension). The heart of this layer is multi-head
self-attention like in [32, 33]. If hi is the feature vector of
node i, then self-attention is computed on the nodes
elij = a
l(Wlhi,Wlhj) (3)
whereWl is a linear transformation called the weight matrix
for the head l, al is a feedforward network outputting a
scalar indexed by the head l. We then normalize these
attention coefficients.
αlij = softmaxj(e
l
ij) =
exp(elij)∑
k∈Ni exp(e
l
ik)
(4)
where Ni is a 1-neighborhood of the node i. The normal-
ized attention coefficients are then used to compute a linear
combination of the features corresponding to them, to serve
as the final output features for every node (after applying a
nonlinearity, σ):
hli = σ
( ∑
j∈Ni
αlijWlhj
)
. (5)
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We concatenate the features of these heads to produce a new
node feature, h′i := ||hli. However, for the final prediction
layer, we average the representations over the heads and
apply a logistic sigmoid non-linearity. Thus the equation for
the final layer is : h′i = σ
(
1
K
∑K
l=1
∑
j∈Ni α
l
ijWlhj
)
,
where K is the number of heads. We create new edge
features Λij for the node eij by concatenating the αlij across
all heads resulting in a K-dimensional edge feature, i.e.
Λij := ||Kl=1αlij (6)
3.3. Our model
In this section we will describe our model that combines
edge features, obtained as described above, with node fea-
tures for our main node classification tasks. We use two
GAT layers to encode the node representations. In the
case of the GAT layers, we concatenate the representations
obtained by different heads resulting in a 64-dimensional
node feature vector. For each node i, we construct a set
Si := {eij : j ∈ Ni}, where eij is the vector representing
the edge features of the edge connecting nodes i and j. We
then encode this set, Si, which we call the edge feature set
attached to the node i via our modified Set Transformer. We
use 2 heads and 1 block of Set Transformer outputting a
8-dimensional vector. This 8-dimensional vector is concate-
nated with the 64-dimensional node representation. We call
this new representation an enhanced node feature vector.
This enhanced node feature vector is then passed through a
dense layer with a logistic sigmoid non-linearity for classi-
fication. Note that instead of GAT layers, we can also use
GCN layers. Thus our method can be used by a variety of
message passing architectures.
4. Experiments
Table 1. Dataset description showing train/val/test splits.
Datasets
SARS-CoV-2
infected organoids COVID-19 patients
# Nodes 54353/11646/11648 63486/13604/13605
# Node features 24714 25626
# Edges 1041226/230429/228630 2746280/703217/707529
# Edge features 18 18
# Classes 7 3
We validate our model on the following scRNA-seq datasets:
(I) 4 human bronchial epithelial cell cultures or “organoids”
that were inoculated with SARS-CoV-2 and co-cultured for
1, 2, and 3 days post-infection [30]; (II) Bronchoalveolar
lavage fluid samples from 12 patients enrolled in a study at
Shenzen Third People’s Hospital in Guangdong Province,
China of whom 3 were healthy controls, 3 had a mild or
moderate form of COVID-19 and 6 had a severe or critical
COVID-19 illness [24]. Table 1 gives a summary of our
datasets.
Creating new edge features : We cluster our datasets using
Louvain clustering [6], and annotate these clusters as “cell
types,” as commonly done in single-cell analysis [21]. Then,
we use a 2-layer GAT with 8 attention heads in each layer
to predict the cell type label. We extract the edge attention
coefficients from the first layer of our trained model as edge
features. Thus we get an 8-dimensional edge feature vector
by equation 6. All of our biological datasets have a batch
ID associated to it, i.e. some metadata that keeps track of
the origin of the cell. We use the same method as before to
create another 8-dimensional edge feature vector. We also
use the Forman-Ricci curvature [11] as a measure of local
geometry of the graph. Finally we use node2vec [16] to
embed the nodes in 16-dimensional space and then we cal-
culate the dot product between the node embeddings, which
share an edge, as a measure of similarity. We concatenate
the above vectors to create a 18 dimensional edge feature
vector.
Table 2. Results of inductive tasks on single-cell datasets showing
accuracy and 95% confidence intervals.
Models
SARS-CoV-2
infected organoids
COVID-19
patients
P
(Welch’s t-test)
GCN 65.43 (65.21-65.65) 89.26 (89.06-89.47) -
GCN + Edge Features (Ours) 81.61 (79.34-83.87) 92.84 (91.95-93.74) < 0.001
GAT 73.10 (70.93-75.27) 92.25 (91.27-93.24) -
GAT + Edge Features (Ours) 82.95 (81.75-84.15) 95.12 (94.02-96.22) < 0.001
5. Discussion
We achieved significant improvements using self-supervised
edge features when comparing our model to the two popular
GNN architectures, GCN and GAT. This suggests that using
edge features derived from self-supervised learning and lo-
cal graph information, with no requirement for hand-crafted
edge features, can improve graph neural network perfor-
mance on challenging node classification tasks. Our models
are simple, easy to train and can be used with various graph
neural network architectures. Additionally, our edge feature
creation framework is applicable to any graphical data.
Given the excellent performance of our GAT with added
edge features at predicting the disease-state at single-cell
level, we sought to use the insight learned from our model
to better understand SARS-CoV-2 infection dynamics and
COVID-19 disease severity on an individual gene and cell
basis. We show the various aspects of model interpretability
that we can glean from our model in Figure 1. First, we ex-
tract the learned, edge attentions from our Set Transformer
and average the coefficients across heads and dimensions
to construct a new adjacency matrix. Then, using a cosine
distance metric, we learn a new embedding of the cells (1A.
In addition, to evaluate the importance of different types of
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Figure 1. Model interpretability to generate hypotheses for genes and cells important to COVID-19 severity. (A) Embedding learned from
graphs extracted from average edge attentions across Set Transformer output dimensions, showing cell type or condition per cell. (B)
Relative importance of crafted edge features in disease state prediction tasks, averaged across the query layer from the Set Transformer.
(C) Top 5 important gene features for each GAT head, colored by normalized, learned weights.
edge features, we plot the average weights of the query layer
in the set transformer (1B). Learning a manifold in this way
shows better segregation of cell types than typically used
for embedding high-dimensional single-cell data, possibly
because our models give weight to cell type labels via their
edge feature representation. In addition, we also extract
the learned weights from our models’ first GAT layer in
order to investigate our model’s feature saliency with re-
spect to gene importance. In predicting COVID-19 severity
from patient samples, our model gives high weight to genes
involved in the innate immune system response to type I
interferon (CCL2, CCL7, IFITM1), regulation of signal-
ing (NUPR1, TAOK1, MTRNR2L12), a component of the
major histocompatibility complex II (HLA-DQA2), which
is important for developing immunity to infection, and a
marker of eosinophil cells, which are involved in fighting
parasites (RETN). In predicting SARS-CoV-2 infection, our
model finds saliency in counts of viral transcript, which is
encouraging, as well as genes that are involved in inflam-
matory response and cell death (NFKBIA) and signaling
(IFI27, HCLS1, NDRG1, NR1D1, TF), which may pro-
vide clues as to the dynamic regulatory response of cells
in the lung’s airways to SARS-CoV-2. The learned em-
bedding for the SARS-CoV-2 infected organoids dataset
highlights that our model segregates infected ciliated cells,
which is the reported SARS-CoV-2 cell tropism, validating
our models’ interpretability [30]. In predicting COVID-
19 severity, it is interesting that our model learns to mix
macrophages and monocytes in a predominantly severe pa-
tient cell cluster while cells derived from mild and severe
COVID-19 patients are mixed in a T cell cluster. Monocytes
derived from macrophages are thought to be enriched in
severe COVID-19 cases and T cells are proposed targets for
immune checkpoint therapy of COVID-19, despite lack of
understanding as to the transcriptional differences between
mild and severe COVID-19 illness [5, 24, 19]. Lastly, it
is interesting that our models find that genes involved in
type I interferon signaling are important in predicting both
COVID-19 severity and susceptibility to SARS-CoV-2 in-
fection. Interferon signaling is involved in pro-inflammatory
immune responses and it is suspected that type I interferon
signaling may cause immunopathology during SARS-CoV-
Self-supervised edge features and GNNs for COVID-19 insight
2 infection, leading to critical illness [30, 19]. Further study
into the interaction partners and the subtle transcriptional
differences between the cells and cell types that we identi-
fied may provide complementary hypotheses or avenues for
therapeutic intervention to mitigate the impacts of COVID-
19. However, we are not medical professionals so we do
NOT claim that interpretation of our model will bear any
fruit. Rather, we hope that the approach of seeking state-
of-the-art results on predicting disease states at single-cell
resolution will enhance study of biology and medicine and
potentially accelerate our understanding of critical diseases
during crises like the COVID-19 pandemic.
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